Wolfgang Hiddemann

Research interests

Publications

• Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

  JAMA Oncology · 2018 · https://doi.org/10.1001/jamaoncol.2017.4996

• Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

  New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1614598

• A 17-gene stemness score for rapid determination of risk in acute leukaemia

  Nature · 2016 · https://doi.org/10.1038/nature20598

• Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2015.63.8387

• Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

  Blood · 2016 · https://doi.org/10.1182/blood-2016-01-693879

• Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)00739-x

• Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

  The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00169-2

• Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

  The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(12)70349-2

• Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

  The Lancet Oncology · 2010 · 10.1016/s1470-2045(10)70071-1

• Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes

  The Lancet · 2010 · https://doi.org/10.1016/s0140-6736(10)62105-8

• An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

  Blood · 2008 · https://doi.org/10.1182/blood-2008-02-134411

• Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.16.8435

• Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.15.4245

• A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

  Blood · 2007 · https://doi.org/10.1182/blood-2007-06-095331

• Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)

  Blood · 2006 · https://doi.org/10.1182/blood-2006-04-016725

• Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

  Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.08.133

• KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

  Blood · 2005 · https://doi.org/10.1182/blood-2005-04-1466

• Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

  Blood · 2005 · https://doi.org/10.1182/blood-2005-06-2248

• AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

  Blood · 2003 · https://doi.org/10.1182/blood-2003-02-0434

• Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

  Blood · 2002 · https://doi.org/10.1182/blood.v100.1.59

• Primary Gastrointestinal Non-Hodgkin’s Lymphoma: I. Anatomic and Histologic Distribution, Clinical Features, and Survival Data of 371 Patients Registered in the German Multicenter Study GIT NHL 01/92

  Journal of Clinical Oncology · 2001 · https://doi.org/10.1200/jco.2001.19.18.3861

• Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

  Nature Genetics · 2001 · https://doi.org/10.1038/85820

• AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia

  Nature Medicine · 2001 · https://doi.org/10.1038/86515

• Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

  Journal of Clinical Oncology · 1999 · https://doi.org/10.1200/jco.1999.17.4.1244

• Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

  The Lancet · 1996 · https://doi.org/10.1016/s0140-6736(96)91681-5

• Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group.

  Journal of Clinical Oncology · 1985 · https://doi.org/10.1200/jco.1985.3.12.1583

• Convention on nomenclature for DNA cytometry

  Cytometry · 1984 · https://doi.org/10.1002/cyto.990050502

Current projects

No projects listed.